These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16702880)

  • 1. Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease.
    Zhang H; Kallwass H; Young SP; Carr C; Dai J; Kishnani PS; Millington DS; Keutzer J; Chen YT; Bali D
    Genet Med; 2006 May; 8(5):302-6. PubMed ID: 16702880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of acarbose inhibition in the measurement of acid alpha-glucosidase activity in blood lymphocytes for the diagnosis of Pompe disease.
    Jack RM; Gordon C; Scott CR; Kishnani PS; Bali D
    Genet Med; 2006 May; 8(5):307-12. PubMed ID: 16702881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new diagnostic assay for glycogen storage disease type II in mixed leukocytes.
    Okumiya T; Keulemans JL; Kroos MA; Van der Beek NM; Boer MA; Takeuchi H; Van Diggelen OP; Reuser AJ
    Mol Genet Metab; 2006 May; 88(1):22-8. PubMed ID: 16359900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved assay for differential diagnosis between Pompe disease and acid α-glucosidase pseudodeficiency on dried blood spots.
    Shigeto S; Katafuchi T; Okada Y; Nakamura K; Endo F; Okuyama T; Takeuchi H; Kroos MA; Verheijen FW; Reuser AJ; Okumiya T
    Mol Genet Metab; 2011 May; 103(1):12-7. PubMed ID: 21320792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease.
    Umapathysivam K; Hopwood JJ; Meikle PJ
    Clin Chem; 2001 Aug; 47(8):1378-83. PubMed ID: 11468225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots.
    Kallwass H; Carr C; Gerrein J; Titlow M; Pomponio R; Bali D; Dai J; Kishnani P; Skrinar A; Corzo D; Keutzer J
    Mol Genet Metab; 2007 Apr; 90(4):449-52. PubMed ID: 17270480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes-possibility for newborn screening.
    Lukacs Z; Nieves Cobos P; Mengel E; Hartung R; Beck M; Deschauer M; Keil A; Santer R
    J Inherit Metab Dis; 2010 Feb; 33(1):43-50. PubMed ID: 20033296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme analysis for Pompe disease in leukocytes; superior results with natural substrate compared with artificial substrates.
    van Diggelen OP; Oemardien LF; van der Beek NA; Kroos MA; Wind HK; Voznyi YV; Burke D; Jackson M; Winchester BG; Reuser AJ
    J Inherit Metab Dis; 2009 Jun; 32(3):416-23. PubMed ID: 19387865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program.
    Chien YH; Chiang SC; Zhang XK; Keutzer J; Lee NC; Huang AC; Chen CA; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL
    Pediatrics; 2008 Jul; 122(1):e39-45. PubMed ID: 18519449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening for Pompe disease in Japan.
    Oda E; Tanaka T; Migita O; Kosuga M; Fukushi M; Okumiya T; Osawa M; Okuyama T
    Mol Genet Metab; 2011 Dec; 104(4):560-5. PubMed ID: 21963784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper.
    Chamoles NA; Niizawa G; Blanco M; Gaggioli D; Casentini C
    Clin Chim Acta; 2004 Sep; 347(1-2):97-102. PubMed ID: 15313146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late onset form of Pompe disease.
    Mattosova S; Hlavata A; Spalek P; Kotysova L; Macekova D; Chandoga J
    Bratisl Lek Listy; 2015; 116(8):502-5. PubMed ID: 26350092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A micro-radiochemical assay for alpha-1,4-glucosidase and its use in the assessment of type II glycogenosis (Pompe's disease).
    Nelson PV; Carey WF; Pollard AC
    Clin Chim Acta; 1977 Jun; 77(3):337-42. PubMed ID: 17494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening for Pompe disease by measuring acid alpha-glucosidase activity using tandem mass spectrometry.
    Dajnoki A; Mühl A; Fekete G; Keutzer J; Orsini J; Dejesus V; Zhang XK; Bodamer OA
    Clin Chem; 2008 Oct; 54(10):1624-9. PubMed ID: 18703766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic and biochemical studies point to AAGR-1 as the ortholog of human acid alpha-glucosidase in Caenorhabditis elegans.
    Sikora J; Urinovská J; Majer F; Poupetová H; Hlavatá J; Kostrouchová M; Ledvinová J; Hrebícek M
    Mol Cell Biochem; 2010 Aug; 341(1-2):51-63. PubMed ID: 20349118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chaperone enhances blood α-glucosidase activity in Pompe disease patients treated with enzyme replacement therapy.
    Parenti G; Fecarotta S; la Marca G; Rossi B; Ascione S; Donati MA; Morandi LO; Ravaglia S; Pichiecchio A; Ombrone D; Sacchini M; Pasanisi MB; De Filippi P; Danesino C; Della Casa R; Romano A; Mollica C; Rosa M; Agovino T; Nusco E; Porto C; Andria G
    Mol Ther; 2014 Nov; 22(11):2004-12. PubMed ID: 25052852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personal Glucose Meter for α-Glucosidase Inhibitor Screening Based on the Hydrolysis of Maltose.
    Tian T; Chen GY; Zhang H; Yang FQ
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two fluorimetric determinations of acid α-glucosidase activity in dried blood spot: Pompe disease in Iranian population.
    Tajmir-Riahi A; Khatami S; Shemirani F; Mirzazadeh R
    Anal Biochem; 2023 Dec; 682():115346. PubMed ID: 37821037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass Spectrometry but Not Fluorimetry Distinguishes Affected and Pseudodeficiency Patients in Newborn Screening for Pompe Disease.
    Liao HC; Chan MJ; Yang CF; Chiang CC; Niu DM; Huang CK; Gelb MH
    Clin Chem; 2017 Jul; 63(7):1271-1277. PubMed ID: 28450385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of acid alpha-glucosidase protein: evaluation as a screening marker for Pompe disease and other lysosomal storage disorders.
    Umapathysivam K; Whittle AM; Ranieri E; Bindloss C; Ravenscroft EM; van Diggelen OP; Hopwood JJ; Meikle PJ
    Clin Chem; 2000 Sep; 46(9):1318-25. PubMed ID: 10973860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.